Terumo Corporation

4543

JP3546800008

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-17 am EDT			5-day change	1st Jan Change
2,724 ^JPY	-2.56%		+3.67%	+17.85%

May. 15	Correction: Terumo’s Profit Up 47% in Fiscal 2024	MT
May. 15	Terumo’s Profit Up 47% in Fiscal 2023	MT

Terumo Corporation Announces Demise of Shogo Ninomiya as Director & Senior Executive Officer

February 26, 2012

Terumo Corporation announce that Director & Senior Executive Officer Shogo Ninomiya, passed away on February 23, 2012 and has retired as Director.

Latest news about Terumo Corporation

Correction: Terumo’s Profit Up 47% in Fiscal 2024	May. 15	MT
Terumo’s Profit Up 47% in Fiscal 2023	May. 15	MT
Transcript : Terumo Corporation, 2024 Earnings Call, May 14, 2024	May. 14
Penumbra, Inc. : The underdog in healthcare	Apr. 11
Frontier Field Co., Ltd. announced that it has received funding from Terumo Corporation	Mar. 17	CI
Jefferies Adjusts Terumo’s Price Target to 6,700 Yen From 5,300 Yen, Keeps at Buy	Mar. 13	MT
Tranche Update on Terumo Corporation's Equity Buyback Plan announced on August 9, 2023.	Mar. 11	CI
Terumo Corporation's Equity Buyback announced on August 9, 2023, has closed with 3,380,000 shares, representing 0.45% for ¥11,097.09 million.	Mar. 07	CI
Terumo Repurchases 521 Million Yen Shares in February	Mar. 04	MT
Terumo Corp to Undertake One-to-Two Share Split	Feb. 08	MT
Terumo's Attributable Profit Climbs 13.8% in Fiscal Nine Months	Feb. 07	MT
Transcript : Terumo Corporation, Q3 2024 Earnings Call, Feb 07, 2024	Feb. 07
Terumo Corporation Reports Earnings Results for the Nine Months Ended December 31, 2023	Feb. 07	CI
Terumo Corporation Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	Feb. 07	CI
Terumo Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	Feb. 07	CI
Terumo Reacquires Over 500,000 Shares in January	Feb. 05	MT
Terumo Repurchases Shares	Jan. 10	MT
Tranche Update on Terumo Corporation's Equity Buyback Plan announced on August 9, 2023.	Jan. 09	CI
Jefferies Adjusts Terumo's Price Target to 5,300 Yen From 4,500 Yen, Keeps at Buy	Jan. 04	MT
Hikaru Samejima to Assume Position as President and CEO of Terumo Corp. in April 2024	Dec. 14	MT
Shinjiro Sato to Leave as CEO of Terumo Corporation on April 1, 2024	Dec. 14	CI
Terumo Corporation Announces Management Changes, Effective from April 1, 2024	Dec. 14	CI
Terumo Repurchases 629,300 Shares in November	Dec. 04	MT
Transcript : Terumo Corporation, Q2 2024 Earnings Call, Nov 15, 2023	Nov. 15
Japanese Shares Continue Winning Streak on Wednesday Amid Rising Hopes on US Rate-Hike Pause	Nov. 15	MT

Terumo Corporation specializes in the design, manufacturing and marketing of medical products and equipments. Net sales break down by family of products as follows: - cardiac surgery devices (53.5%); - medical products for hospitals (28.6%): medical devices, nutritional additives, oxygen, medical measuring devices (thermometers, tensiometers, glucometers, etc.), etc.; - sanguine transfusion equipments (17.9%). Net sales break down geographically as follows: Japan (32.9%), America (29.5%), Europe (19.6%), China (7.4%) and other (10.6%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-06 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Terumo Corporation

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2,724 JPY

Average target price

2,992 JPY

Spread / Average Target

+9.88%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
TERUMO CORPORATION	+17.85%	26.02B
ABBOTT LABORATORIES	-5.43%	181B
MEDTRONIC PLC	+4.30%	114B
BECTON, DICKINSON AND COMPANY	-3.09%	68.29B
DEXCOM, INC.	+5.86%	52.24B
CENCORA, INC.	+8.15%	44.3B
HOYA CORPORATION	+7.52%	42.73B
METTLER-TOLEDO INTERNATIONAL, INC.	+25.54%	32.52B
WEST PHARMACEUTICAL SERVICES, INC.	+1.00%	25.91B
ZIMMER BIOMET HOLDINGS, INC.	-1.25%	24.72B

Other Medical Equipment, Supplies & Distribution